Wordt geladen...
Fluconazole resistance in Candida species: a current perspective
Candida albicans and the emerging non-albicans Candida spp. have significant clinical relevance among many patient populations. Current treatment guidelines include fluconazole as a primary therapeutic option for the treatment of these infections, but it is only fungistatic against Candida spp. and...
Bewaard in:
| Gepubliceerd in: | Infect Drug Resist |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546770/ https://ncbi.nlm.nih.gov/pubmed/28814889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S118892 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|